コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
1 Surgical embolectomy and/or venoarterial ECMO were compared, between 2005 and 2019, for massive PE (MPE) ve
4 , neuropsychological testing and emotional/behavioural data were compared between CTE and AD subjects at the time of deme
5 Clinical data, including CDI severity and CDI risk factors, were compared between discordant test results.
6 s vault, anterior chamber depth, and anterior chamber area, were compared between early PACD (PACS) and late PACD (PAC an
8 tide), cardiac reverse remodeling, and health status scores were compared between groups using multivariate latent growth
9 (ED) visits, and outpatient clinic encounters before age 1 were compared between groups via logistic regression models.
11 tment outcomes (cure, failure, death, or loss to follow-up) were compared between groups with respect to glycemic status
13 ined as the proportion of patients with at least 1 adenoma) were compared between groups, with a noninferiority margin (r
16 d conditions, endoscopic findings, treatments, and outcomes were compared between immunocompetent and immunocompromised.
17 Biopsy-proven acute rejection (BPAR) rates and types were compared between indigenous and nonindigenous recipients
20 Flare detection sensitivity and specificity were compared between 'minimal' baseline and 6 week sample CR
21 ncy department visit, psychiatric hospitalization, suicide) were compared between mothers and siblings and their controls
22 ges from pre to post-conditioning (DeltaMQST and DeltaTQST) were compared between OA and control dogs.
27 al presentation, antiviral and immunosuppressive management were compared between patients with mild/moderate and severe
28 recurrence-free survival (RFS), and HCC recurrence (HCC-R) were compared between patients within MC (n = 3,570) and beyo
30 absence of choroidal involvement, and quantitative metrics were compared between subgroups and normal control subjects.
33 Geometric mean titers (GMTs) and seropositivity rates were compared between the different groups at different time
35 Specific procedure parameters and treatment regimens were compared between the group of eyes with and without ACI.
37 ions with standard automated perimetry (SAP) global indices were compared between the human gradings vs the M2M DL-predic
38 d major cardiovascular and cerebrovascular events [MACCEs]) were compared between the matched groups using a stratified l
39 assess relative validity, calculated dietary folate intakes were compared between the MGDB and the EPIC nutrient database
40 ation dataset, the receiver operating characteristics (ROC) were compared between the models trained in the centralized a
41 entage, the control metric, were computed, and their values were compared between the normal and DR eyes.
42 e network and bridge centrality, and the network properties were compared between the outbreak and after peak.
43 dth, percentage of root coverage, patient-centered outcomes were compared between the two groups.
45 ardized mortality ratios, and standardized incidence ratios were compared between treatment groups and with the US popula
46 Changes in ECD, CV, and %HEX from baseline to 3 months were compared between treatment groups using 2-sample t tests
49 nge in OCTA size, vessel density, and vessel length density were compared between visits as predictors of progression to